Sage Journals: Discover world-class research

Abstract

The purpose of this research was to collect information concerning the systems which hospitals have developed to monitor and report adverse drug events (ADE). In addition, the attitudes and perceptions of those coordinating the program toward postmarketing surveillance of such events were investigated. The sample was stratified by hospital size. Questionnaires were sent to 725 Joint Commission for Accreditation of Health Care Organization accredited hospitals (305 small, 275 medium, and 145 large). Completed questionnaires were received from 306 respondents, representing a 42% overall response rate. Differences among the three groups were seen in the professional personnel involvement in the monitoring activities, reporters of ADEs, and dissemination of ADE information. Pharmacists had the biggest role in implementing this function and concurrent review methods generated the greatest percentage of ADEs. Overall, the systems were similar among hospitals of different sizes.

Keywords

Adverse drug event reporting MedWatch Hospital pharmacy Adverse reactions

Get full access to this article

View all access options for this article.

References

Johnson

Tanner

. Postmarketing Surveillance: Curriculum for the Clinical Pharmacologist. Part I: Postmarketing Surveillance Within the Continuum of the Drug Approval Process. Clin Pharmacol. 1993;33(10):907.

Sills

Tanner

Milsien

. Food and Drug Administration Monitoring of Adverse Drug Reactions. Am J Hosp Pharm. 1986;43:2764.

Wood

. Postmarketing Surveillance: Viewpoint from a Regulatory Authority. Drug Inf J. 1991; 25(2): 192.

Rogers

. Adverse Drug Events: Identification and Attribution. Pharmacoepidem. 1987;21:916.

May

Stewart

Hale

Marks

. Prescribed and Nonprescribed Drug Use in an Ambulatory Elderly Population. South Med J. 1982;75(5): 522–528.

Faich

Knapp

Dreis

Turner

. National Adverse Drug Reaction Surveillance. JAMA. 1987; 257(15):2069.

Kessler

. Introducing MedWatch. JAMA. 1993; 269(21):2765.

Seidl

Thornton

Smith

. Studies on the Epidemiology of Adverse Drug Reactions. Bull Johns Hopkins Hosp. 1966;119:303.

Sleel

Gertman

Crescenzi

. Iatrogenic Illness on a General Medicine Service at a University Hospital. N Eng J Med. 1981;304:639.

10.

Porter

Jick

. Drug Related Deaths Among Medical Inpatients. JAMA. 1977;237:879–881.

11.

Joint Commission on Accreditation of Hospitals. Accreditation Manual for Hospitals. 1993.

12.

American Society of Hospital Pharmacists. ASHP Guidelines on Adverse Drug Reaction Monitoring and Reporting. Am J Hosp Pharm. 1989;46:336–337.

13.

Hoffman

. Adverse Drug Reactions Revisited—JCAHO. Hosp Pharm. 1988;23:686.

14.

Anon. AHA Guide to Health Care Field. Chicago, IL; 199.

15.

Crawford

Myers

. ASHP National Survey of Hospital-Based Pharmaceutical Services—1992. Am J Hosp Pharm. 1993;50:1371–1404.

16.

Ostrosky

. Database Uses E-Codes to Isolate ADR Information. Drug Util Rev. 1986;2(6):79–105.

17.

Schumock

Thornton

Witte

. Comparison of Pharmacy-Based Concurrent Surveillance and Medical Record Retrospective Reporting of Adverse Drug Reactions. Am J Hasp Pharm. 1991;48:1974–1976.

18.

Classen

Pestotnik

Evans

Burke

. Computerized Surveillance of Adverse Drug Events in Hospital Patients. JAMA. 1991;266(20):2847–2852.

A National Survey of Hospital Adverse Drug Event Monitoring and Reporting Systems

Abstract

Keywords

Get full access to this article

References